The Identification Distinct Antiviral Factors Regulated Influenza Pandemic H1N1 Infection

Area of Science:

• Virology
• Immunology
• Genomics

Background:

• Influenza pandemic H1N1 (H1N1pdms) leads to severe lung damage and cytokine storms, causing significant mortality in humans and animals.
• Understanding host antiviral molecular mechanisms is critical for developing effective H1N1pdms therapies.

Purpose of the Study:

• To analyze multimicroarray data from mouse lungs infected with H1N1pdm and nonpandemic H1N1 strains.
• To identify differentially expressed genes (DEGs) and understand host immune responses to H1N1pdms.

Main Methods:

• Organized and analyzed multimicroarray data from mouse lungs.
• Compared gene expression profiles between H1N1pdms infected and control lungs.
• Identified and functionally characterized differentially expressed genes (DEGs).

Main Results:

• H1N1pdms infection caused a significant increase in DEGs over time in mouse lungs.
• Innate immune responses were similar across different H1N1pdm strains.
• DEGs were concentrated in viral defense, cytokine signaling, innate immunity regulation, and interferon response pathways.
• Ten distinct DEGs (AREG, CXCL13, GATM, GPR171, IFI35, IFI47, IFIT3, ORM1, RETNLA, UBD) were identified, enriched in immune response and cell surface receptor signaling.

Conclusions:

• H1N1pdms infection profoundly impacts host gene expression, particularly in immune-related pathways.
• Specific DEGs identified may serve as therapeutic targets for broad-spectrum influenza treatments.
• Findings offer insights into host responses to pandemic influenza, aiding in the development of novel therapies.